Progress in stem cell‐based therapy for liver disease
G Shiota, N Itaba - Hepatology Research, 2017 - Wiley Online Library
Liver transplantation has been accepted as a useful therapeutic approach for patients with
end‐stage liver disease. However, the mismatch between the great demand for liver …
end‐stage liver disease. However, the mismatch between the great demand for liver …
[引用][C] Progress in stem cell-based therapy for liver disease
G Shiota, N Itaba - Hepatology Research, 2017 - jglobal.jst.go.jp
Progress in stem cell-based therapy for liver disease | Article Information | J-GLOBAL Art J-GLOBAL
ID:201702269120065354 Reference number:17A0386320 Progress in stem cell-based …
ID:201702269120065354 Reference number:17A0386320 Progress in stem cell-based …
[引用][C] Progress in stem cell-based therapy for liver disease
G Shiota, N Itaba - Hepatology Research, 2016 - cir.nii.ac.jp
Progress in stem cell-based therapy for liver disease | CiNii Research CiNii 国立情報学研究所
学術情報ナビゲータ[サイニィ] 論文・データをさがす 大学図書館の本をさがす 日本の博士論文をさがす …
学術情報ナビゲータ[サイニィ] 論文・データをさがす 大学図書館の本をさがす 日本の博士論文をさがす …
Progress in stem cell‐based therapy for liver disease
G Shiota, N Itaba - Hepatology Research, 2017 - infona.pl
Liver transplantation has been accepted as a useful therapeutic approach for patients with
end‐stage liver disease. However, the mismatch between the great demand for liver …
end‐stage liver disease. However, the mismatch between the great demand for liver …
Progress in stem cell-based therapy for liver disease
G Shiota, N Itaba - … research: the official journal of the …, 2017 - pubmed.ncbi.nlm.nih.gov
Liver transplantation has been accepted as a useful therapeutic approach for patients with
end-stage liver disease. However, the mismatch between the great demand for liver …
end-stage liver disease. However, the mismatch between the great demand for liver …
Progress in stem cell-based therapy for liver disease.
G Shiota, N Itaba - Hepatology Research: the Official Journal of the …, 2016 - europepmc.org
Liver transplantation has been accepted as a useful therapeutic approach for patients with
end-stage liver disease. However, the mismatch between the great demand for liver …
end-stage liver disease. However, the mismatch between the great demand for liver …